Novartis https://www.reuters.com/markets/companies/NOVN.S” target=”_blank” rel=”noopener”>(NOVN.S) on Tuesday raised its full-year earnings forecast for the second time on strong drug sales and mapped out the planned separation and stock market debut of its gen…
Read More
